Imricor Medical Systems
Imricor Medical Systems develops the only commercially available MRI-compatible electrophysiology products for cardiac ablation — including catheters, a 3D mapping system, and EP recorders — selling to hospitals and academic medical centers performing arrhythmia treatment.
- Company typePublic
- Founded2006
- HeadquartersMinneapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Imricor Medical Systems does
Imricor Medical Systems is a Burnsville, Minnesota-based medical device company that develops and commercializes the only commercially available suite of interventional cardiac magnetic resonance (iCMR) products for catheter ablation of cardiac arrhythmias. Founded in 2006 by Steve Wedan — a former GE Healthcare MRI and ultrasound design engineer — the company has spent nearly two decades engineering catheters, recording systems, and mapping platforms that are safe and functional inside the bore of an MRI scanner, eliminating the X-ray fluoroscopy that has historically guided EP procedures.
The product portfolio comprises four integrated components sold as an ecosystem: the Vision-MR Ablation Catheter 2.0 and Vision-MR Diagnostic Catheter (the only MR-compatible ablation and diagnostic EP catheters with active MR tracking), the Advantage-MR EP Recorder/Stimulator (an MR-conditional EP amplifier and cardiac stimulator), and the NorthStar Mapping System (the first and only MRI-Native 3D mapping and guidance system, FDA-cleared in February 2026). Accessories include the Vision-MR Dispersive Electrode. The platform enables real-time visualization of cardiac anatomy, catheter position, and lesion formation during ablation, addressing the principal limitations of X-ray-guided EP — poor soft tissue contrast, ionizing radiation exposure, and inability to assess lesion quality intra-procedure.
The company generates revenue through capital equipment sales (mapping systems, recorders) and recurring disposable catheter sales to hospitals and academic cardiac centers performing EP procedures. Customers are major institutions including Leipzig Heart Centre, Amsterdam UMC, Charité, Haga Hospital, Semmelweis University, CHUV, Johns Hopkins, and UVA Health, with more than 11 active iCMR sites across Europe, the Middle East, Australia/New Zealand, and now the United States following the April 2026 U.S. commercial launch. Distribution combines direct sales (particularly in the U.S.) with regional channel partners (Philips, NordicNeuroLab, Sana Einkauf & Logistik, Regional Health Care Group, FMS Saudi Arabia), and the technology is integrated with MRI scanners from GE HealthCare, Siemens Healthineers, and Philips. The company is publicly listed on the ASX (IMR) and remains in a capital-intensive growth phase, having raised approximately A$68M cumulatively through multiple rounds, including a ~A$43M placement in May 2026 to fund U.S. commercialization.
Imricor Medical Systems firmographics
Firmographics- Name
- Imricor Medical Systems
- Legal name
- Imricor Medical Systems, Inc.
- Website
- https://imricor.com
- Company type
- Public
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Imricor Medical Systems develops the only commercially available MRI-compatible electrophysiology products for cardiac ablation — including catheters, a 3D mapping system, and EP recorders — selling to hospitals and academic medical centers performing arrhythmia treatment.
- Ownership category
- akta.pro rank
Imricor Medical Systems industry classification
Industry- Product category
- Cardiac Electrophysiology Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD)
Keywords
Where Imricor Medical Systems is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Imricor Medical Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others
Revenue model
- Medical Device Sales: Sale of proprietary MRI-compatible catheters (ablation and diagnostic), EP recorder/stimulator systems, and mapping systems to hospitals and cardiac ablation centers. Revenue generated through direct equipment sales and ongoing disposable catheter products.
- Disposable Products: Single-use catheters and disposable products consumed during each procedure, providing recurring revenue from established customer sites.
Go-to-market motion1 record
Distribution channels6 records
Marketing channels7 records
Imricor Medical Systems product offering
Product offeringCore offering
Imricor develops and manufactures an integrated ecosystem of magnetic resonance imaging (MRI)-compatible electrophysiology devices, including MR-conditional ablation and diagnostic catheters, a 3D mapping and guidance system, and an EP recorder/stimulator. The company's iCMR (interventional cardiac MRI) platform enables physicians to perform real-time, radiation-free cardiac ablation procedures for arrhythmias such as atrial flutter, atrial fibrillation, and ventricular tachycardia.
Product overview
Imricor Medical Systems offers an integrated ecosystem of MRI-compatible (iCMR) products for cardiac ablation procedures. The portfolio consists of the Vision-MR Ablation Catheter 2.0 (the first and only MR-compatible ablation catheter with active tracking), the Vision-MR Diagnostic Catheter (first and only MR-compatible diagnostic catheter), the Advantage-MR EP Recorder/Stimulator (electrophysiology recording and stimulation system), and the NorthStar Mapping System (3D mapping and guidance platform). The Vision-MR Dispersive Electrode completes the accessory line. All products are designed for use within interventional MRI environments, enabling real-time soft tissue visualization during cardiac procedures without X-ray radiation.
Differentiator
Problem solved
Functional benefit
Brands
- iCMR: Interventional Cardiovascular Magnetic Resonance - the company's core technology platform enabling real-time MRI-guided cardiac ablation procedures
- Vision-MR
- NorthStar Mapping System
- Advantage-MR EP Recorder/Stimulator
Products and services
- Vision-MR Ablation Catheter 2.0 The first and only MR-compatible cardiac ablation catheter with patented technology enabling safe, real-time ablation during active MRI scanning. Features active MR tracking, fiber optic tip temperature sensing, enhanced deflection control, and comes in two curve sizes (32mm and 48mm). Single-use RF ablation catheter with 9.5Fr bipole irrigated-tip design.
- Vision-MR Diagnostic Catheter The first and only MR-compatible diagnostic catheter enabling safe, real-time electrophysiological mapping during active MRI scanning. Features active MR tracking with one MR receive coil in the distal end. 9Fr catheter with atraumatic smooth tip for diagnostic procedures.
- Advantage-MR EP Recorder / Stimulator An electrophysiology amplifier and recording system with integrated cardiac stimulator for use within the iCMR environment. Combines a conventional EP recording system with cardiac stimulator functionality to display and record intracardiac electrograms, pacing, and tip temperature monitoring during MRI-guided ablation.
- NorthStar Mapping System First and only cardiac mapping and guidance system designed specifically to harness MR imaging for real-time visualization during minimally-invasive procedures. Provides real-time visibility of anatomy, catheters, and lesion formation with 3D shell display, ablation point tracking, real-time device tracking, and electrophysiology integration.
- Vision-MR Dispersive Electrode An accessory dispersive electrode designed to minimize eddy currents induced on conductive pads during MR scanning. CE marked for use with MRI-guided cardiac ablation procedures.
Quantifiable outcome
- 100% chronic success rate in clinical study for type 1 atrial flutter treatment
- +3 more outcomes
Companies that use Imricor Medical Systems
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
Imricor Medical Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature6 records
Imricor Medical Systems partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Amsterdam University Medical CentrecoreClinical collaboration for first in human ischemic VT ablation under real-time MRI guidance, representing world-first procedural achievements.
- ADIScoreJoint Development Agreement for AI modules in NorthStar Mapping System, adding artificial intelligence capabilities to the mapping platform.
- FMS (Saudi Arabia)minorLandmark distribution agreement with leading distributor in Saudi Arabia for Middle East market expansion.
- GE HealthCarecoreMemorandum of Understanding signed for collaboration in interventional cardiac MRI. GE HealthCare is a major MRI scanner manufacturer, making this partnership critical for integrating Imricor's iCMR products with GE's imaging platforms.
- Siemens HealthineerscoreSigned agreement enabling 3D mapping system integration with Siemens MRI scanners. Strategic relationship to improve cardiac ablations by combining real-time MRI with 3D-guided navigation.
- MIPMminorDevelopment agreement with MIPM for advancing interventional MRI technology for cardiac procedures.
- NordicNeuroLabminorSales agreement covering Nordic markets for Imricor's MRI-guided cardiac ablation products.
- Regional Health Care GroupminorDistribution agreement expanding reach to Australia and New Zealand for the full Imricor product portfolio.
- PhilipsminorFirst sales collaboration agreement with Philips for MRI-guided cardiac ablation products. Philips is a major healthcare technology company.
- Sana Einkauf & LogistikminorMaster Purchasing Agreement with Sana, Germany's largest group purchasing organization, facilitating access to German hospital networks.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Imricor Medical Systems competitors and assessment
Company assessmentDirect peers
- Biosense Webster: Johnson & Johnson's electrophysiology division and the global market leader in catheter ablation and 3D cardiac mapping (CARTO system). Direct peer to Imricor in cardiac ablation, with much broader commercial reach but no MRI-compatible offering.
- Abbott: Major electrophysiology player offering the EnSite X 3D cardiac mapping system and ablation catheters across all major arrhythmia indications. Direct competitor to Imricor in cardiac ablation; significantly larger scale and broader product portfolio.
- Boston Scientific: Established EP competitor with the Rhythmia mapping system and a full ablation catheter portfolio, including recent expansion into pulsed-field ablation. Direct peer to Imricor in cardiac ablation technology and target customers.
- Medtronic: Diversified cardiac device leader with a strong electrophysiology franchise, including cryoablation and the Affera mapping and ablation platform. Direct competitor in EP ablation and a key source of Imricor's executive talent.
Emerging players
- Stereotaxis: Public small-cap developing robotic magnetic navigation systems for cardiac ablation. Smaller and earlier-stage than the EP majors, with an alternative technology approach to the same electrophysiology procedures Imricor targets.
- Acutus Medical: Electrophysiology company developing non-contact mapping and ablation technologies for arrhythmias. Comparable in scale and stage to Imricor, focused on the same EP procedure market but with a different technological approach (ultrasound vs. MRI).
- CathVision: Developer of advanced EP recording systems (ECGenius) used during cardiac ablation procedures. Adjacent technology overlap with Imricor's Advantage-MR EP Recorder/Stimulator for signal acquisition during ablation.
Broad incumbents
- Philips: Major healthcare technology and MRI manufacturer with which Imricor has a sales collaboration. Comparable in that Philips is a critical partner/channels for iCMR procedures through its MRI installed base and broader image-guided therapy portfolio.
- Siemens Healthineers: Global MRI and image-guided therapy leader with which Imricor has a 3D mapping integration agreement. Comparable as both partner and potential competitive platform incumbent in the MRI-based interventional environment.
- GE HealthCare: Major MRI scanner manufacturer (led by Steve Wedan's former employer) with which Imricor has an MoU for interventional cardiac MRI collaboration. Comparable as both a strategic channel partner and incumbent imaging platform whose installed base determines Imricor's accessible market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Imricor Medical Systems social profiles
Digital presenceImricor Medical Systems compliance and trust
Trust signalCompliance4 records
Imricor Medical Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imricor Medical Systems leadership team
Management profileNumber of profiles
Profiles15 records
Imricor Medical Systems funding detail
Funding detailFunding overview
Funding rounds11 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imricor Medical Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imricor Medical Systems
What does Imricor Medical Systems do?
Imricor develops and manufactures an integrated ecosystem of magnetic resonance imaging (MRI)-compatible electrophysiology devices, including MR-conditional ablation and diagnostic catheters, a 3D mapping and guidance system, and an EP recorder/stimulator. The company's iCMR (interventional cardiac MRI) platform enables physicians to perform real-time, radiation-free cardiac ablation procedures for arrhythmias such as atrial flutter, atrial fibrillation, and ventricular tachycardia.
Is Imricor Medical Systems a public or private company?
Imricor Medical Systems is a public company. It is classified as public and is currently operating.
When was Imricor Medical Systems founded?
Imricor Medical Systems was founded in 2006. It employs 11 to 50 people.
Where is Imricor Medical Systems based?
Imricor Medical Systems is headquartered in Minneapolis, United States, in the North America region.
How does Imricor Medical Systems make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are disposable Products.
Who are Imricor Medical Systems's main competitors?
Direct peers on record are Biosense Webster, Abbott, Boston Scientific and Medtronic. Emerging players are Stereotaxis, Acutus Medical and CathVision. Broad incumbents are Philips, Siemens Healthineers and GE HealthCare.
Does Imricor Medical Systems have an API?
No public API is recorded for Imricor Medical Systems.
What industry is Imricor Medical Systems in?
Imricor Medical Systems's product category is Cardiac Electrophysiology Devices. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems. Its NAICS code is 334510 and its SIC code is 3845.